Trial NCT03036930

Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients

This trial studies whether the nonavalent human papillomavirus vaccine given to adults prior to kidney transplantation can help the body build and maintain an effective immune response during the post-transplant period when they receive immunosuppressive drugs to prevent transplant rejection. This study will help inform our scientific understanding about vaccine-induced immune responses among immunosuppressed individuals.


Laboratory Biomarker Analysis, Questionnaire Administration, Recombinant Human Papillomavirus Nonavalent Vaccine


Kidney Transplantation


Lisa Rahangdale, Garrett R. Roll, E. T. Overton, Michael Ison, Irene Kim

See list of participating sites